← FDA Drug Approvals (Drugs@FDA)

ZERBAXA

NDA · New Drug Application · Sponsor: CUBIST PHARMS LLC · Approved 2014-12-19

Drug application

FDA Application #

NDA206829

Application type

New Drug Application

Brand name

ZERBAXA

Generic name

CEFTOLOZANE AND TAZOBACTAM

Active ingredients

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CUBIST PHARMS LLC

Manufacturer

Merck Sharp & Dohme LLC

First approval

2014-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown